Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Efficacy of Force Modulating Tissue Bridge Device in Preventing Hypertrophic Scars Following Gender-Affirming Mastectomy: A Randomized Self-Controlled Trial

NCT07147166 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT07147166
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07147166 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Efficacy of Force Modulating Tissue Bridge Device in Preventing Hypertrophic Scars Following Gender-Affirming Mastectomy: A Randomized Self-Controlled Trial
Lead sponsor
University of California, San Francisco
Phase
Not applicable
Overall status
Terminated
Start date
February 3, 2025
Completion date
August 18, 2026
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gender dysphoria, hypertrophic scar, mastectomy